Skip to main navigation Skip to search Skip to main content

Icahn School of Medicine at Mount Sinai Home

Help & FAQ Link opens in a new tab

Search content at Icahn School of Medicine at Mount Sinai

Home
Profiles
Research units
Publications & Research Outputs
Press/Media

Monthly: Kalvista Pharmaceuticals (KALV: $11.39) rises 28% on high volatility in February 2025

Meredith Smith,

Icahn School of Medicine at Mount Sinai

Press/Media

Period	3 Mar 2025

Powered by Pure Link opens in a new tab, Scopus Link opens in a new tab & Elsevier Fingerprint Engine™ Link opens in a new tab

All content on this site: Copyright © 2026 Icahn School of Medicine at Mount Sinai, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

About web accessibility Link opens in a new tab

Report vulnerability Link opens in a new tab